skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.

Journal Article · · Toxicology, 199(2-3):169-183

Interactions between carcinogens in mixtures found in the environment have been a concern for several decades. In the present study, male B6C3F1 mice were used to study the responses to mixtures of dichloroacetate (DCA), trichloroacetate (TCA), and tetrachloride (CT), each of which acts by a different mode of action. Mice were initiated by vinyl carbamate (VC), and then promoted by DCA, TCA, CT, or the pair-wised combinations of the three compounds. The effect of each treatment or treatment combination on tumor number/animal and tumor size was individually assessed in each animal. Dose-related increases in tumor size were observed with 20 & 50 mg/kg CT, but each produced equal number of tumors at 36 weeks. As the dose of CT was increased to > 100 mg/kg substantial increases in the number of tumors per animal were observed, but the mean tumor size decreased. When administered alone in the drinking water at 0.1, 0.5 and 2 g/L, DCA increased both tumor number and tumor size in a dose-related manner. TCA treatment produced dose-related increases in tumor number at 36 weeks of treatment. For TCA treatment at 2 g/L in drinking water a maximum tumor number was reached by 24 weeks and was maintained until 36 weeks of treatment. DCA treatment did produce a plateau in tumor number, but the numbers observed at the end of the experimental period where similar to TCA and CT. Treatment of mice receiving a high dose of TCA (2 g/L of drinking water) combined with varying doses of DCA (0.1, 0.5 and 2 g/L) produced increased numbers of tumors at 24 weeks and 36 weeks. At 36 weeks of treatment DCA produced a dose-related decrease in the size of tumors promoted by TCA. On the other hand, the low dose of TCA (0.1 g/L) decreased the number of tumors produced by a high dose of DCA, but higher doses of TCA produced the same number as observed with DCA alone. The inhibitory effect on number was not explained by differences in tumor size. DCA inhibited the growth rate of CT-induced tumors (CT dose = 50 mg/kg). TCA substantially increased the numbers of tumors observed early with CT-induced tumors, but coalescence of tumors by 36 weeks appeared to mask this difference. These data suggest that the interactions between tumor promoters are dependent upon their modes of action and the selective advantage they provide to initiated cells. These conditions may be complimentary and additive or competitive and inhibitory. No evidence of synergy was observed.

Research Organization:
Pacific Northwest National Lab. (PNNL), Richland, WA (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RL01830
OSTI ID:
15010612
Report Number(s):
PNWD-SA-6534
Journal Information:
Toxicology, 199(2-3):169-183, Journal Name: Toxicology, 199(2-3):169-183
Country of Publication:
United States
Language:
English

Similar Records

Using Mode of Action to Assess Health Risks from Mixtures of Chemical/Physical Agents
Technical Report · Mon Jan 20 00:00:00 EST 2003 · OSTI ID:15010612

Effects of Dichloroacetate on Glycogen Metabolism in B6C3F1 Mice
Journal Article · Tue Sep 15 00:00:00 EDT 1998 · Toxicology · OSTI ID:15010612

The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse
Journal Article · Fri Feb 01 00:00:00 EST 1991 · Fundamental and Applied Toxicology; (United States) · OSTI ID:15010612

Related Subjects